SAT0576 Biomarkers predictive of pain improvement in knee osteoarthritis subjects treated with the anti-il-1 alpha/beta dual variable domain immunoglobulin lutikizumab (ABT-981) - Feng, S.; Chen, S.; Wang, L.; Peterfy, C.; Kraus, V.; Kamath, R.; Zhang, L.; Luo, Y.; Cui, L.; Medema, J.; Levesque, M. (Annals of the rheumatic diseases, 2018)
Keywords: Alkaline phosphatase; Biomarkers; Cell activation; Clinical trials; Data processing; Demography; Drug development; Interleukin 1; Knee; Macrophages; Magnetic resonance imaging; Osteoarthritis; Osteophytes; Pain; Patients; Pharmaceutical industry; Population studies; Stockholders; Synovitis; Ultrasound